Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3036955	s-afmaksa	% (—)	79	86	100.00%	Distribution not available
3036955	s-afluu	% (—)	77	84	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Abnormal serum enzyme levels

18.52

10.17

2.2

2.5

—

Abnormal findings on examination of blood, without diagnosis

6.51

9.70

2.2

2.3

—

Diseases of liver

5.66

7.06

2.2

2.1

—

Postmenopausal atrophic vaginitis

5.52

4.79

1.8

2.3

—

Primary_lymphoid and hematopoietic malignant neoplasms

8.75

3.77

2.6

2.3

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3.26

3.56

2.1

2.2

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.41

3.19

2.1

2.2

—

Pain in limb

2.63

2.93

2.1

2.2

—

Headache

2.67

2.92

2.1

2.2

—

Any gastric operation

2.58

2.87

2.3

2.1

—

GASTRO-related operations

2.58

2.87

2.3

2.1

—

Other diseases of liver

5.39

2.86

2.3

—

Nausea and vomiting

5.30

2.83

2.3

2.1

—

Abnormal findings on diagnostic imaging of other body structures

8.34

2.75

2.4

2.0

—

Gestational [pregnancy-induced] hypertension

4.20

2.67

2.5

2.0

—

Gastro-oesophageal reflux disease

2.53

2.52

1.9

2.2

—

Basal cell carcinoma

3.59

2.48

2.2

2.0

—

Basal cell carcinoma, including avohilmo

3.38

2.34

2.2

2.0

—

Speech therapy

3.89

2.25

2.4

2.0

—

Antihypertensive medication - note that there are other indications

2.63

2.24

2.3

2.2

—

Chronic rhinitis, nasopharyngitis and pharyngitis

3.33

2.17

2.0

2.2

—

Other diseases of pleura

3.65

2.09

2.3

2.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

2.85

2.07

2.3

2.2

—

Other soft tissue disorders, not elsewhere classified

2.20

2.02

2.1

2.2

—

Diseases of oesophagus, stomach and duodenum

2.02

1.97

2.1

2.2

—

Major coronary heart disease event

0.00

1.94

0.0

2.1

—

Malignant neoplasm

2.16

1.92

2.2

2.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2.03

1.85

2.1

2.2

—

Hypothyroidism, strict autoimmune

2.21

1.83

2.3

2.1

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

2.90

1.80

2.3

2.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

2.57

1.80

2.0

2.1

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

2.75

1.70

2.3

2.0

—

Depression medications

3.20

1.70

2.3

1.9

—

Abnormal findings on diagnostic imaging of lung

2.84

1.67

2.0

2.3

—

Fitting and adjustment of other devices

2.83

1.65

2.3

2.2

—

Other nutritional deficiencies

2.17

1.64

2.5

2.1

—

Symptoms and signs involving the skin and subcutaneous tissue

2.13

1.59

2.3

2.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.98

1.57

2.1

—

Autoimmune diseases excluding thyroid diseases

1.97

1.56

2.1

—

Pain (limb, back, neck, head abdominally)

2.17

1.54

2.3

2.2

—

Oral corticosteroids

1.90

1.54

2.0

2.2

—

Iridocyclitis

3.33

1.52

2.4

2.3

—

Other diseases of blood and blood-forming organs, wide

3.33

1.52

2.0

2.1

—

Medical treatment for female infertility

3.33

1.52

2.0

2.3

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.91

1.51

2.3

2.1

—

First line medication for Crohn's disease

1.89

1.48

2.0

2.2

—

Renal failure

3.26

1.48

2.0

2.3

—

Used for control exclusion in common control thyroid runs

1.93

1.45

2.3

2.1

—

Covid-19 suspected case

3.13

1.44

2.0

2.2

—

Disorders of breast

2.12

1.43

2.4

2.1

—

General symptoms and signs

1.84

1.43

2.2

—

Any event in cancer register

1.93

1.42

2.1

—

Dermatitis and eczema

1.83

1.41

2.1

2.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

1.85

1.41

2.0

2.2

—

Other pulmonary diagnosis

2.00

1.39

2.1

2.3

—

Sciatica+with lumbago

2.25

1.39

2.0

2.2

—

Chronic diseases of tonsils and adenoids

1.90

1.38

1.9

2.2

—

Injuries to the neck

2.94

1.36

2.0

2.4

—

Other diseases of anus and rectum

2.94

1.35

2.4

2.1

—

Diseases of the musculoskeletal system and connective tissue

2.26

1.34

2.2

2.4

—

Soft tissue disorders

1.85

1.31

2.1

2.2

—

Acute tubulo-interstitial nephritis

2.10

1.29

2.0

2.3

—

Diagnoses used for exclusion with ILD

2.78

1.28

2.0

2.2

—

Chronic gastritis

2.78

1.28

2.4

2.1

—

General examination and investigation of persons without complaint and reported diagnosis

2.22

1.28

2.1

2.2

—

Aplastic and other anaemias

2.47

1.28

2.0

2.2

—

Obesity due to excess calories

2.29

1.26

2.5

2.1

—

Other antidepressants

1.81

1.25

2.3

2.2

—

Autoimmune diseases

1.82

1.25

2.3

2.1

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1.88

1.25

2.1

—

Malignant neoplasm, wide definition for exclusion

1.88

1.25

2.1

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1.88

1.25

2.1

—

Pregnancy hypertension

2.03

1.24

2.4

2.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

2.00

1.23

2.0

2.1

—

Disturbances of skin sensation

2.63

1.21

2.0

2.2

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2.19

1.20

2.3

2.0

—

Acute sinusitis

2.13

1.19

2.1

2.2

—

Other disorders of urethra and urinary system

1.91

1.18

2.0

2.3

—

Medical observation and evaluation for suspected diseases and conditions

2.13

1.17

2.3

2.2

—

Injuries to the head

0.44

1.16

2.0

2.2

—

Other heart diseases

2.06

1.16

2.6

2.1

—

Pain, not elsewhere classified

2.50

1.15

2.4

2.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

2.11

1.14

2.6

2.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

2.40

1.14

2.3

2.1

—

Hypothyroidism and >3 levothyroxin purchases

2.61

1.12

2.8

1.9

—

Hypothyroidism, levothyroxine purchases

2.61

1.12

2.8

1.9

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.99

1.12

2.4

2.1

—

Hypothyroidism (congenital or acquired)

2.61

1.12

2.8

1.9

—

Disorders of skin appendages

2.00

1.12

2.8

2.1

—

Bronchitis

1.69

1.08

2.0

2.2

—

Neoplasms

1.89

1.08

2.3

2.1

—

Other diseases of urinary system

1.70

1.06

2.0

2.2

—

Irritable bowel syndrome

2.27

1.03

2.0

—

Malaise and fatigue

2.08

1.03

2.3

2.1

—

Obesity and other hyperalimentation

1.90

1.03

2.4

2.1

—

Other menopausal disorders

2.40

1.03

2.0

2.3

—

Female infertility

2.38

1.03

2.0

2.5

—

Parodontitis and operation codes

1.74

1.00

2.3

2.1

—

Hypothyroidism, other/unspecified

1.71

0.99

2.3

2.1

—

Other and unspecified anaemias

2.20

0.99

2.0

2.1

—

Other anaemias

2.19

0.98

2.0

2.1

—

Persons encountering health services for examination and investigation

1.88

0.98

2.2

—

Gastrointestinal diseases

1.88

0.98

2.2

2.0

—

ILD medications

1.66

0.98

2.0

2.2

—

COPD/asthma/ILD related infections

1.64

0.98

2.0

2.2

—

COPD/asthma related infections

1.64

0.98

2.0

2.2

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

2.17

0.98

2.0

2.1

—

Acute upper respiratory infections of multiple and unspecified sites

1.83

0.98

2.0

2.2

—

Fever of other and unknown origin

1.97

0.98

2.3

2.2

—

Codes for special purposes

1.94

0.97

2.3

2.2

—

Provisional assignment of new diseases of uncertain etiology

1.94

0.97

2.3

2.2

—

Parodontitis or/and operation codes

1.92

0.96

2.4

2.2

—

Genitourinary diseases

2.31

0.95

2.0

2.6

—

Bacterial infection, other or unspecified

1.91

0.94

2.0

2.1

—

Symptoms and signs involving the digestive system and abdomen

1.71

0.94

2.3

2.2

—

Other diseases of upper respiratory tract

1.64

0.93

1.9

2.3

—

Acute bronchitis

2.18

0.92

2.0

2.3

—

Obesity, other/unspecified

2.14

0.91

2.3

2.1

—

Injuries to the wrist and hand

0.49

0.91

2.4

2.1

—

Constipation

1.69

0.91

2.0

2.2

—

Disorders of the thyroid gland

1.66

0.91

2.3

2.1

—

Other/unspecified dorsalgia

2.13

0.91

2.0

2.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2.06

0.88

2.0

2.1

—

Renal tubulo-interstitial diseases

1.70

0.87

2.0

2.2

—

Other reaction to severe stress, and adjustment disorders

2.00

0.87

2.3

2.1

—

Gonarthrosis, primary, with knee surgery

1.82

0.85

2.3

2.2

—

Dental caries 1 and operation codes, only avohilmo

0.00

0.84

0.0

2.1

—

Diseases of the respiratory system

1.78

0.84

2.2

2.3

—

Presence of other functional implants

1.77

0.83

2.5

2.1

—

Excluding asthma or asthma-COPD overlap

1.72

0.82

2.1

2.3

—

Appendectomy

1.75

0.82

2.1

2.2

—

Coxarthrosis

1.75

0.82

2.0

2.2

—

Chronic periodontitis, including avohilmo

1.63

0.81

2.3

2.1

—

Coronary revascularization (ANGIO or CABG)

0.00

0.81

0.0

2.1

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1.87

0.81

2.7

2.0

—

Parodontitis

1.62

0.80

2.3

2.1

—

Artificial joint operation, meniscal resection

1.63

0.80

2.2

—

Parodontitis or operation codes

1.62

0.80

2.3

2.1

—

Degeneration of macula and posterior pole

0.00

0.80

0.0

2.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.59

0.79

2.3

2.1

—

Abnormalities of breathing

1.60

0.79

2.1

2.2

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

0.00

0.79

0.0

2.1

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

0.00

0.79

0.0

2.3

—

L02BG Aromatase inhibitors

1.82

0.79

2.7

2.0

—

Diseases of external ear

0.00

0.79

0.0

2.2

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

0.00

0.78

0.0

2.3

—

Other medical care

0.00

0.78

0.0

2.2

—

Hypertensive diseases (excluding secondary)

1.76

0.77

2.6

2.1

—

COPD differential diagnosis

1.67

0.76

2.1

2.3

—

ILD differential diagnosis

1.67

0.76

2.1

2.3

—

Retinal detachments and breaks

0.00

0.76

0.0

2.1

—

Malignant neoplasm of breast, HER2-negative

1.70

0.75

2.3

2.0

—

Obesity

1.71

0.75

2.4

2.1

—

Any reimbursement code in KELA

1.67

0.75

2.4

2.1

—

Malignant neoplasm of breast

1.66

0.74

2.3

2.0

—

Diaphragmatic hernia

2.08

0.74

1.8

2.1

—

Other and unspecified iron deficiency

2.08

0.74

2.0

2.2

—

Dental caries

2.06

0.74

2.4

2.0

—

Endocrine, nutritional and metabolic diseases

1.65

0.74

2.3

2.1

—

Ovarian cyst

2.07

0.73

2.4

—

Malignant neoplasm of skin

1.82

0.73

2.0

2.1

—

Selective serotonin reuptake inhibitors

1.57

0.72

2.1

2.2

—

Fracture of shoulder and upper arm

2.00

0.72

2.8

2.1

—

Coxarthrosis, primary, with hip surgery

1.97

0.72

2.0

2.1

—

Persons encountering health services for specific procedures and health care

1.52

0.72

2.1

2.2

—

Falls/tendency to fall

0.57

0.72

2.4

2.1

—

Accidents

0.51

0.70

2.2

2.1

—

Other external causes of accidental injury

0.51

0.70

2.2

2.1

—

Low back pain

1.67

0.70

2.0

2.2

—

Exposure to other specified factors

1.56

0.70

2.2

2.1

—

Carpal tunnel syndrome

1.56

0.70

2.2

2.1

—

Dorsopathies

1.55

0.70

2.1

2.2

—

Autoimmune diseases related-to ILD

1.58

0.69

2.2

2.1

—

Disorders of vitreous body

1.67

0.68

2.3

2.1

—

Disorders of sclera, cornea, iris and ciliary body

1.67

0.68

2.6

2.0

—

Lower back pain or/and sciatica

1.52

0.68

2.0

2.2

—

Diverticular disease of intestine

1.66

0.67

2.2

2.1

—

Disorders of vitreous body and globe

1.63

0.66

2.3

2.1

—

Iron deficiency anaemia

1.77

0.65

2.0

2.3

—

Syncope and collapse

1.77

0.65

2.4

2.2

—

Acute appendicitis, no complications

1.59

0.65

2.1

2.2

—

Noninflammatory disorders of female genital tract

1.80

0.64

2.4

—

Coxarthrosis [arthrosis of hip](FG)

1.65

0.63

2.0

2.2

—

Parasetamol

1.60

0.62

2.4

2.2

—

Poisoning by medicine

0.00

0.60

0.0

2.3

—

Lyme disease

0.00

0.60

0.0

2.2

—

Other spirochaetal diseases

0.00

0.60

0.0

2.2

—

Poisoning by drugs, medicaments and biological substances

0.00

0.60

0.0

2.3

—

Other diseases of intestines

1.48

0.60

2.2

—

Haemorrhage from respiratory passages

0.00

0.60

0.0

2.0

—

Alcohol dependence

0.00

0.59

0.0

2.2

—

Type of accident

0.00

0.59

0.0

2.3

—

Other diseases of hard tissues of teeth

1.59

0.59

2.0

2.1

—

Diseases of oral cavity, salivary glands and jaws

0.53

0.58

2.4

2.1

—

Arthropathies

1.50

0.58

2.2

—

Salpingitis and oophoritis

0.00

0.58

0.0

2.0

—

Suicide or other Intentional self-harm

0.00

0.58

0.0

2.2

—

Sulfasalazine

0.00

0.58

0.0

2.2

—

Insulin, intermediate and long-acting

1.73

0.58

2.3

2.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1.73

0.58

2.0

2.3

—

Care involving use of rehabilitation procedures

1.49

0.57

2.1

2.2

—

Other acute lower respiratory infections

1.68

0.57

2.0

2.2

—

Asthma (only as main-diagnosis), excluding more controls

1.58

0.56

2.0

2.3

—

Asthma (only as main-diagnosis)

1.55

0.56

2.0

2.3

—

Malignant neoplasm of breast, HER-positive

1.60

0.55

2.7

2.0

—

Inflammatory bowel disease treatment related agents

1.45

0.55

2.0

2.2

—

Medicines for HER+ breast cancer

1.58

0.54

2.7

2.0

—

Asthma, excluding more controls

1.57

0.53

2.0

2.3

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.48

0.53

2.2

2.1

—

Triptan medication for migraine, single purchase ok

1.48

0.53

2.2

2.1

—

Benzodiazepine use

1.45

0.53

2.0

2.2

—

Cardiovascular diseases

1.44

0.53

2.4

2.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.54

0.53

2.3

2.1

—

Other and unspecified disorders of vitreous body

1.53

0.52

2.0

2.1

—

Dizziness and giddiness

1.43

0.52

2.1

2.2

—

Injuries to the shoulder and upper arm

1.52

0.52

2.4

2.1

—

Other and unspecified dermatitis

1.50

0.51

2.0

2.2

—

Abdominal and pelvic pain

1.47

0.50

2.3

2.2

—

Cholelithiasis

1.45

0.50

2.3

2.1

—

Asthma

1.53

0.49

2.0

2.3

—

Asthma (mode)

1.53

0.49

2.0

2.3

—

Osteopathies and chondropathies

1.54

0.48

2.1

2.2

—

Dermatitis

1.52

0.48

2.0

2.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.48

0.47

2.3

2.1

—

Persons encountering health services in other circumstances, wide

1.40

0.46

2.1

2.2

—

Sleep apnoea, including avohilmo

1.41

0.46

2.3

2.1

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1.43

0.46

2.4

2.0

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1.43

0.46

2.4

2.0

—

ILD medications: immunosuppressive drugs

1.43

0.46

2.0

2.2

—

Gonarthrosis,primary

1.42

0.45

2.1

—

Cholelithiasis, broad definition with cholecystitis

1.42

0.45

2.3

2.1

—

Opioids

1.39

0.45

2.2

—

Contraceptive management

1.41

0.45

2.3

2.1

—

Asthma, including avohilmo

1.36

0.45

2.0

2.2

—

1.37

0.45

2.0

2.2

—

Cardiovascular diseases (excluding rheumatic etc)

1.48

0.44

2.6

2.1

—

Mouth breathing

1.61

0.43

2.0

2.1

—

Cystitis

1.43

0.43

2.0

2.3

—

Other arrhythmias

1.42

0.42

2.3

2.0

—

Other abnormal uterine and vaginal bleeding

0.00

0.42

0.0

2.4

—

Anxiety disorders, excluding more controls

1.40

0.42

2.3

2.1

—

Diabetes mellitus in pregnancy

1.54

0.42

2.8

2.0

—

Injuries to the knee and lower leg

1.34

0.41

2.0

2.2

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.41

0.0

2.3

—

Other and unspecified nerve root and plexus disorders, also in other diseases

0.00

0.41

0.0

2.2

—

Persistent mood disorders

0.00

0.41

0.0

2.2

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.00

0.41

0.0

2.3

—

HSIL lesion of the cervix uteri

0.00

0.41

0.0

2.3

—

Car occupant injured in other and unspecified transport accidents

0.00

0.41

0.0

2.3

—

HSIL lesion of the cervix uteri, vagina or vulva

0.00

0.41

0.0

2.3

—

Otitis externa

0.00

0.40

0.0

2.2

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.38

0.40

2.5

2.1

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.40

0.0

2.2

—

Acute alcohol intoxication

0.00

0.40

0.0

2.2

—

Neurotic, stress-related and somatoform disorders

1.38

0.40

2.3

2.1

—

Anxiety disorders

1.37

0.39

2.3

2.1

—

Visual disturbances

1.43

0.39

2.0

2.1

—

Other noninfective gastroenteritis and colitis

0.00

0.39

0.0

2.2

—

Disorders of other endocrine glands

1.41

0.38

1.8

2.1

—

Nutritional anaemias

1.39

0.38

2.0

2.2

—

Other abnormal products of conception

1.39

0.38

2.0

2.2

—

Other anxiety disorders

1.39

0.38

2.8

2.1

—

Use of hypnotics and sedatives

1.34

0.37

2.0

2.2

—

Arthrosis

1.41

0.36

2.1

2.2

—

Appendicitis, broad definition

1.27

0.36

2.1

2.2

—

Diseases of appendix

1.26

0.36

2.1

2.2

—

Certain infectious and parasitic diseases

1.32

0.36

2.1

2.2

—

Complications of surgical and medical care, not elsewhere classified

1.34

0.35

2.2

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.33

0.34

2.1

2.2

—

Spondylosis

1.35

0.34

2.0

2.2

—

Insulin medication

1.35

0.34

2.3

2.1

—

Exclusions for E4_PCOS_CONSORTIUM

0.67

0.34

2.3

2.1

—

Dental pulpitis 1, only avohilmo

1.31

0.33

2.4

2.1

—

Dental pulpitis 4, only avohilmo

1.31

0.33

2.4

2.1

—

Acute upper respiratory infections

1.31

0.33

2.0

2.2

—

Disorders of eyelid, lacrimal system and orbit

0.68

0.33

2.7

2.1

—

Diseases of the eye and adnexa

1.34

0.32

2.3

2.1

—

Other (not insulin) diabetes medications

0.69

0.31

2.3

2.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.35

0.31

2.1

—

Type 2 diabetes, strict (exclude DM1)

0.68

0.31

2.3

2.1

—

Type 2 diabetes, definitions combined

0.68

0.31

2.3

2.1

—

Biguanides

0.68

0.31

2.3

2.1

—

Nerve, nerve root and plexus disorders

1.30

0.31

2.2

—

Diseases of the skin and subcutaneous tissue

1.30

0.31

2.3

2.1

—

Injuries to the ankle and foot

1.28

0.30

2.3

2.1

—

Triptan medication for migraine, min. 3 purchases

1.26

0.28

2.0

2.2

—

Dental pulpitis 2

0.69

0.27

2.8

2.1

—

Acute appendicitis

1.24

0.27

2.1

2.2

—

Other intervertebral disc disorders

1.28

0.26

2.2

2.3

—

Pain in throat and chest

1.29

0.26

2.1

2.2

—

Dorsalgia

1.29

0.26

2.2

—

Disorders of gallbladder, biliary tract and pancreas

1.27

0.25

2.3

2.1

—

Statin medication

0.72

0.25

2.7

2.1

—

Asthma, hospital admissions , main diagnosis only

1.20

0.25

2.0

2.2

—

Benign neoplasm of colon, rectum, anus and anal canal

1.32

0.23

2.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.30

0.23

2.0

2.2

—

Diseases of the ear and mastoid process

0.79

0.23

2.1

2.2

—

Disorders of vestibular function (Vertigo)

1.27

0.22

2.0

2.1

—

Recurrent or chronic depression

1.25

0.22

2.4

2.2

—

Other headache syndromes

1.25

0.22

2.0

2.1

—

Infections of the skin and subcutaneous tissue

1.24

0.22

2.4

2.2

—

Finngen Rheumatological endpoints

1.24

0.22

2.0

2.2

—

Visual disturbances and blindness

1.22

0.22

2.0

2.1

—

Other dorsopathies, not elsewhere classified

1.26

0.22

1.9

2.2

—

Coronary artery bypass grafting

0.00

0.22

0.0

2.3

—

Later onset COPD

0.00

0.22

0.0

2.3

—

Outcome of delivery

0.00

0.21

0.0

2.3

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

0.00

0.21

0.0

2.4

—

Heart failure and coronary heart disease

0.00

0.21

0.0

2.4

—

Maternal care for known or suspected fetal abnormality and damage

0.00

0.21

0.0

2.2

—

Fracture of femur

0.00

0.21

0.0

2.4

—

Asthma, unspecified (mode), excluding more controls

1.19

0.21

2.0

2.3

—

Calcific aortic valvular stenosis, including rheumatic fever

0.00

0.21

0.0

2.4

—

Operations 2 for CAVS

0.00

0.21

0.0

2.4

—

Calcific aortic valvular stenosis, diagnosis (helper)

0.00

0.21

0.0

2.4

—

Calcific aortic valvular stenosis

0.00

0.21

0.0

2.4

—

Calcific aortic valvular stenosis, operated

0.00

0.21

0.0

2.4

—

Benign neoplasm of breast

0.00

0.21

0.0

2.0

—

Psoriatic and enteropathic arthropathies

0.00

0.21

0.0

2.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.21

0.0

2.0

—

0.00

0.21

0.0

2.0

—

Hallux rigidus

0.00

0.21

0.0

2.0

—

Thyrotoxicosis with diffuse goitre

0.00

0.21

0.0

2.1

—

Lateral epicondylitis

0.00

0.21

0.0

2.1

—

Tumor necrosis factor alpha inhibitors

0.00

0.21

0.0

2.0

—

Trigger finger

0.00

0.21

0.0

2.1

—

Methotrexate

0.00

0.21

0.0

2.1

—

Alcohol abuse, main dg, excluding more controls

0.00

0.21

0.0

2.2

—

Alcohol abuse, main dg

0.00

0.21

0.0

2.2

—

Azathioprine

0.00

0.21

0.0

2.2

—

Acute pancreatitis (for exclusion)

0.00

0.21

0.0

2.2

—

Acute pancreatitis

0.00

0.21

0.0

2.4

—

Acute alcohol intoxication, ICD10

0.00

0.21

0.0

2.2

—

Peritonsillar abscess

0.00

0.21

0.0

2.5

—

0.00

0.21

0.0

2.2

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

0.21

0.0

2.3

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

0.00

0.21

0.0

2.2

—

Atrophic disorders of skin

0.00

0.21

0.0

2.0

—

Retinal breaks without detachment

0.00

0.21

0.0

2.2

—

Biological medication for rheuma

0.00

0.21

0.0

2.0

—

Aneurysms, operations, SAH

0.00

0.21

0.0

2.2

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

0.21

0.0

2.0

—

Generalized anxiety disorder

0.00

0.21

0.0

2.2

—

Other hammer toe(s) (acquired)

0.00

0.21

0.0

1.9

—

Insomnia

0.00

0.21

0.0

2.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.21

0.0

2.3

—

Benign neoplasm: Colon, unspecified

0.00

0.21

0.0

2.2

—

Exclusions for E4_PCOS_BROAD

0.00

0.21

0.0

2.3

—

Coxarthrosis, primary

1.27

0.20

2.0

2.1

—

Intestinal infectious diseases

1.25

0.20

2.2

—

Retained placenta and membranes, without haemorrhage

0.00

0.20

0.0

2.1

—

Corneal ulcer

0.00

0.20

0.0

2.1

—

Other fall from one level to another

0.00

0.20

0.0

2.3

—

Other arthrosis

1.23

0.20

2.2

2.1

—

Reimbursement for rheumatic diseases

1.20

0.19

2.0

2.2

—

Tonsillectomy and adenotomy

1.16

0.19

1.8

2.2

—

Gonarthrosis [arthrosis of knee](FG)

1.25

0.19

2.1

2.2

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1.25

0.19

2.6

2.1

—

Implicit Sepsis

1.18

0.18

2.3

2.1

—

Depression or dysthymia

1.15

0.18

2.0

2.2

—

Hypertensive diseases

1.22

0.17

2.5

2.1

—

Hypertension

1.22

0.17

2.5

2.1

—

Pure hypercholesterolaemia

0.76

0.17

2.8

2.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.21

0.17

2.1

2.2

—

Shoulder lesions

1.19

0.17

2.1

2.2

—

Gonarthrosis

1.18

0.17

2.1

2.2

—

Tramadol

0.79

0.16

2.0

2.1

—

Complications of procedures, not elsewhere classified

1.10

0.15

2.3

2.2

—

Dyspnoea

1.17

0.15

2.2

2.1

—

Other bacterial diseases

1.21

0.15

2.2

2.1

—

Type 2 diabetes, wide definition

1.13

0.15

2.4

2.1

—

Asthma (diagnoses ohter than nonallergic)

1.15

0.15

2.0

2.2

—

Any mental disorder

0.83

0.15

2.2

2.1

—

Benign neoplasms

0.77

0.15

2.3

2.1

—

Hernia

1.09

0.15

1.9

2.2

—

Other disorders of ear

0.79

0.15

2.1

2.2

—

Mood disorders, excluding more controls

0.81

0.14

2.5

2.1

—

Asthma/COPD (KELA code 203)

1.17

0.13

2.0

2.2

—

Other heart diseases, wide

1.18

0.13

2.5

2.1

—

Polycystic ovarian syndrome, consortium definition

1.18

0.12

2.4

2.1

—

Codeine

1.16

0.11

2.4

2.2

—

Asthma, unspecified (mode)

1.17

0.10

2.0

2.3

—

Pain in joint

1.14

0.10

2.0

2.2

—

Glaucoma

1.15

0.10

2.4

2.1

—

Primary gonarthrosis, bilateral

1.15

0.10

2.4

2.2

—

Asthma-related infections

1.07

0.09

2.0

2.2

—

Asthma, hospital admission 2, infections

1.07

0.09

2.0

2.2

—

Diseases of inner ear

1.06

0.09

2.0

2.1

—

Meniscus derangement

1.14

0.09

2.3

2.2

—

All anxiety disorders

1.12

0.09

2.7

2.0

—

Migraine

1.11

0.09

2.0

2.1

—

Anxiety (asthma-related co-morbidities)

1.07

0.08

2.7

2.1

—

Dislocation, sprain and strain of joints and ligaments of knee

1.07

0.08

2.0

2.2

—

Irregular menses

1.06

0.08

2.7

2.1

—

Persons encountering health services in circumstances related to reproduction

0.79

0.08

2.0

2.1

—

Other specific joint derangements/joint disorders

0.78

0.08

2.0

2.2

—

Symptoms and signs involving the urinary system

0.79

0.08

1.8

2.2

—

Varicose veins

1.10

0.08

1.9

2.1

—

Heart failure, not strict

1.05

0.08

2.3

2.1

—

Pregnancy with abortive outcome

0.83

0.08

2.3

2.2

—

Dental pulpitis 2, only avohilmo

1.11

0.08

2.5

2.1

—

Conjunctivitis

1.06

0.07

2.3

2.1

—

Leiomyoma of uterus

0.87

0.07

2.3

2.0

—

Other joint disorders

1.09

0.07

2.4

2.2

—

Gingivitis and periodontal diseases

0.86

0.07

2.3

2.1

—

Diabetes, insulin treatment (Kela reimbursement)

1.12

0.07

2.4

2.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

0.85

0.07

2.0

2.2

—

Exposure to unspecified factor

0.87

0.07

2.3

2.1

—

Pneumonias (Asthma/COPD co-morbidities)

0.84

0.07

2.0

2.2

—

Chronic lower respiratory diseases

1.07

0.02

2.0

2.2

—

All pneumoniae

1.08

0.02

2.0

2.2

—

Diabetes mellitus

0.93

0.01

2.4

2.1

—

Depression

1.08

0.01

2.4

2.1

—

Diabetes, varying definitions

0.93

0.01

2.4

2.1

—

Neurological diseases

1.07

0.01

2.2

2.1

—

Type 2 diabetes

0.94

0.00

2.4

2.1

—

Symptoms and signs involving the circulatory and respiratory systems

1.06

0.00

2.1

2.2

—

Diseases of pulp and periapical tissues, including avohilmo

1.04

0.00

2.5

2.1

—

Dental pulpitis 4

1.04

0.00

2.5

2.1

—

Codeine or tramadol medication

0.97

0.00

2.4

2.1

—

Dental pulpitis 1

1.04

0.00

2.5

2.1

—

Mood [affective] disorders

0.97

0.00

2.4

2.1

—

Diabetes medication

0.95

0.00

2.4

2.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.02

0.00

2.4

2.1

—

Mood disorders

0.97

0.00

2.4

2.1

—

Sleep disorders (combined)

0.99

0.00

2.6

2.1

—

Influenza and pneumonia

1.00

0.00

2.0

2.2

—

Fall on same level

1.03

0.00

2.3

2.1

—

Episodal and paroxysmal disorders

0.97

0.00

2.2

2.1

—

Psychiatric diseases

1.04

0.00

2.2

2.1

—

Otitis externa, unspecified

0.00

0.0

2.0

—

Other maternal disorders predominantly related to pregnancy

0.94

0.00

2.6

2.1

—

Non-small cell lung cancer

0.00

0.0

2.4

—

Pain in thoracic spine

0.00

0.0

2.3

—

Adenomyosis (Endometriosis of uterus)

0.00

0.0

2.4

—

Excessive vomiting in pregnancy

0.00

0.0

2.0

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

0.00

0.0

2.2

—

Inflammatory diseases of prostate (prostatitis)

0.00

0.0

2.4

—

Cardiac arrhythmias

1.02

0.00

2.3

2.0

—

Sarcoidosis

0.00

0.0

2.0

—

Burns and corrosions

0.00

0.0

2.3

—

Bitten or struck by other mammals

0.00

0.0

2.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

0.91

0.00

2.0

2.1

—

Cholecystectomy

1.00

0.00

2.6

2.1

—

Abdominal aortic aneurysm (AAA)

0.00

0.0

2.4

—

Medical abortion

0.86

0.00

2.0

2.2

—

Other and unspecified injuries of lower leg

0.00

0.0

2.0

—

Other specified/unspecified hearing loss

0.00

0.0

2.0

—

Other diseases of jaws

0.00

0.0

2.0

—

Myocardial infarction, unclassifiable

0.00

0.0

2.5

—

Malignant neoplasm of bronchus and lung

0.00

0.0

2.4

—

Rotator cuff syndrome

0.98

0.00

2.0

2.1

—

Eustachian salpingitis and obstruction

0.00

0.0

2.0

—

Injury of muscle and tendon at wrist and hand level

0.00

0.0

2.2

—

Retinal detachment with retinal break

0.00

0.0

2.3

—

Other disorders of the genitourinary system

0.00

0.0

2.0

—

COPD-related respiratory insufficiency

0.00

0.0

2.3

—

0.00

0.0

2.3

—

Disorders of psychological development

0.00

0.0

2.4

—

Conduction disorders

0.00

0.0

2.0

—

Dental caries 3, only avohilmo

0.95

0.00

2.5

2.1

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.0

2.0

—

Peripheral arterial reconstruction

0.00

0.0

2.6

—

Other psoriatic arthropathies

0.00

0.0

2.0

—

Congenital malformations, deformations and chromosomal abnormalities

1.02

0.00

2.4

2.1

—

Other noninflammatory disorders of vulva and perineum

0.00

0.0

2.3

—

Abnormal involuntary movements

0.00

0.0

2.3

—

Uterine polyps

0.00

0.0

2.3

—

Monoamine oxidase A inhibitors

0.00

0.0

2.4

—

Sequelae of injuries of lower limb

0.00

0.0

2.0

—

Superficial injury of thorax

0.00

0.0

2.3

—

Gout, unspecified

0.00

0.0

2.3

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.0

1.8

—

Injuries to the elbow and forearm

0.89

0.00

2.2

—

Open wound of lower leg

0.00

0.0

2.3

—

Benign neoplasm of breast

0.00

0.0

2.0

—

Type 2 diabetes, definitions combined, including avohilmo

0.90

0.00

2.2

2.1

—

Other complications of surgical and medical care, not elsewhere classified

0.00

0.0

2.0

—

Lung cancer and mesothelioma

0.00

0.0

2.3

—

Contact with machinery

0.00

0.0

2.4

—

Other condition

0.00

0.0

2.3

—

Leisure time condition

0.00

0.0

2.3

—

Infections of genitourinary tract in pregnancy

0.00

0.0

2.0

—

Arthropathic psoriasis

0.00

0.0

2.0

—

Hyperkinetic disorders

0.00

0.0

2.3

—

Problems related to lifestyle

0.00

0.0

2.4

—

Benign neoplasm: Colon, unspecified

0.00

0.0

2.3

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.0

2.3

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

0.0

2.3

—

Other obstetric trauma

0.00

0.0

2.3

—

STROKE

0.85

0.00

2.0

2.1

—

Vulvovaginal ulceration/inflammation in other diseases

0.00

0.0

2.0

—

Eating disorder

0.00

0.0

2.4

—

Other respiratory disorders and diseases

0.00

0.0

2.5

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

0.96

0.00

2.0

2.2

—

Chronic periodontitis, complicated

0.00

0.0

2.4

—

Acute laryngitis and tracheitis

0.00

0.0

2.0

—

Dental caries 1

1.02

0.00

2.5

2.1

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

0.0

2.0

—

Acute nasopharyngitis (common cold)

0.00

0.0

2.3

—

Dental caries, including avohilmo

1.02

0.00

2.5

2.1

—

Dental caries 3 and operation codes

0.98

0.00

2.5

2.1

—

Dental caries 1 and operation codes

1.00

0.00

2.5

2.1

—

ILD medications: azathioprine

0.00

0.0

2.3

—

Dental caries 1, only avohilmo

0.97

0.00

2.5

2.1

—

Carcinoma in situ of cervix uteri

0.00

0.0

2.3

—

Benign neoplasms

1.03

0.00

2.3

2.1

—

Disorders of conjunctiva

1.01

0.00

2.3

2.1

—

Injury of eye and orbit

0.00

0.0

2.2

—

Gout, idiopatic and unspecified

0.00

0.0

2.4

—

Psoriatic arthropathies, ICD10

0.00

0.0

2.0

—

Prolonged pregnancy

0.00

0.0

2.3

—

Intrahepatic Cholestasis of Pregnancy (ICP)

0.00

0.0

2.0

—

Assault

0.00

0.0

2.0

—

Follow-up examination after treatment for malignant neoplasms

0.00

0.0

2.0

—

Retinal vascular occlusion

0.00

0.0

2.0

—

Pneumonia, organism unspecified

0.95

0.00

2.0

2.2

—

Other and unspecified vascular occlusions

0.00

0.0

2.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.02

0.00

2.3

2.2

—

Other specified and unspecified personality disorders

0.00

0.0

2.0

—

Retinal vascular disorders

0.00

0.0

2.0

—

Other keratitis

0.00

0.0

2.0

—

Other embolism and thrombosis

0.00

0.0

2.0

—

Complications of labour and delivery

0.97

0.00

2.0

2.2

—

Mixed conductive and sensorineural hearing loss

0.00

0.0

2.0

—

Other blood glucose lowering drugs, excl. Insulins

0.00

0.0

2.3

—

Degenerative macular diseases

0.00

0.0

2.0

—

Inguinal or femoral hernia, bilateral

0.00

0.0

2.4

—

Other noninflammatory disorders of vagina

0.00

0.0

2.3

—

Bell's palsy

0.00

0.0

2.3

—

Congenital malformations of genital organs

0.00

0.0

2.0

—

Fibromyalgia

0.00

0.0

2.2

—

Carcinoma in situ of cervix uteri

0.00

0.0

2.3

—

Dermatophytosis

0.00

0.0

2.4

—

Hyperkinetic disorders, excluding more controls

0.00

0.0

2.0

—

Sleep apnoea

0.95

0.00

2.4

2.1

—

Postprocedural disorders of nervous system

0.00

0.0

2.0

—

Inguinal hernia, bilateral

0.00

0.0

2.4

—

Subarachnoid haemorrhage

0.00

0.0

2.0

—

Eating disorders

0.00

0.0

2.3

—

Unspecified acute lower respiratory infection

0.00

0.0

2.2

—

severe traumatic brain injury, does not include concussion

0.00

0.0

2.4

—

Benign neoplasm of colon, rectum, anus and anal canal

1.00

0.00

2.0

2.1

—

Lesion of ulnar nerve

0.00

0.0

2.2

—

Other sleep disorders

0.00

0.0

2.0

—

Unspecified/other endometriosis

0.00

0.0

2.4

—

Allergic conjunctivitis

0.85

0.00

2.0

2.2

—

Spondylopathies

0.89

0.00

2.0

2.2

—

Other diseases of the respiratory system

0.00

0.0

2.5

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

0.00

0.0

2.0

—

Fracture of lumbar spine and pelvis

0.00

0.0

2.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.00

0.0

2.4

—

Noninfectious colitis NAS

0.00

0.0

2.3

—

Wet age-related macular degeneration

0.00

0.0

2.3

—

Diseases of the myoneural junction and muscle

0.00

0.0

2.0

—

0.96

0.00

2.0

2.2

—

Gout, strict definition

0.00

0.0

2.3

—

Deep endometriosis

0.00

0.0

2.0

—

Artrosis, including avohilmo

0.93

0.00

2.1

2.2

—

Inflammatory diseases of female pelvic organs

0.96

0.00

2.0

2.1

—

Other disorders of skin and subcutaneous tissue

0.86

0.00

3.2

2.1

—

Metabolic disorders

0.96

0.00

2.7

2.1

—

Benign neoplasm: Sigmoid colon

0.00

0.0

2.3

—

Intracerebral haemorrhage

0.00

0.0

2.3

—

Dementia in Alzheimer disease

0.00

0.0

2.4

—

Other disorders of the musculoskeletal system and connective tissue

0.00

0.0

2.3

—

Disturbance of activity and attention

0.00

0.0

2.0

—

Hypertension, essential

1.01

0.00

2.4

2.1

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.0

3.0

—

Lumbar disc prolapse

0.97

0.00

2.0

2.2

—

Graves disease, strict definition

0.00

0.0

2.2

—

Nontraumatic intracranial haemmorrhage

0.00

0.0

2.4

—

Coeliac disease

0.00

0.0

2.0

—

Polyarthropathies

1.00

0.00

2.0

2.2

—

Psoriatic arthropathies

0.00

0.0

2.0

—

Polymyalgia rheumatica

0.00

0.0

2.0

—

Reactive arthropathies

0.00

0.0

2.0

—

Use of memantine

0.00

0.0

2.3

—

Use of donepezil

0.00

0.0

2.3

—

Other puerperal infections

0.00

0.0

2.3

—

Use of other anti-dementia drugs

0.00

0.0

2.3

—

Dental caries 3

1.00

0.00

2.5

2.1

—

Use of rivastigmine

0.00

0.0

2.3

—

Seronegative rheumatoid arthritis

0.00

0.0

2.0

—

KRA_PSY_EATING, excluding more controls

0.00

0.0

2.0

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

-0.00

0.0

2.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS